← United States · Coverage record
US · SEC FORM 4
EyePoint, Inc.
EYPT · Nasdaq · CIK 0001314102 · Healthcare · Biotechnology
INSIDER SIGNAL
1 qualifying P purchase group
in the current 180-day scoring window
11 Form 4 transaction lines observed in the same window
2 sales · 8 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-08-18 · Zaderej Karen L..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 20,788,240
- Previous report
- 19,809,561
- Avg daily volume
- 3,863,442
- Days to cover
- 5.4
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Zaderej Karen L. | Purchase (P) | Common Stock | 10,600 | USD 4.93 | USD 52,258 | SEC filing ↗ |
| 2026-03-16 | Duker Jay S. | Purchase (P) | Common Stock | 1,500 | USD 13.15 | USD 19,725 | SEC filing ↗ |
| 2025-05-19 | Zaderej Karen L. | Purchase (P) | Common Stock | 5,000 | USD 5.99 | USD 29,950 | SEC filing ↗ |
| 2025-05-16 | Zaderej Karen L. | Purchase (P) | Common Stock | 5,000 | USD 5.81 | USD 29,050 | SEC filing ↗ |
| 2025-05-15 | Zaderej Karen L. | Purchase (P) | Common Stock | 5,000 | USD 5.47 | USD 27,350 | SEC filing ↗ |
| 2025-05-14 | Zaderej Karen L. | Purchase (P) | Common Stock | 5,000 | USD 5.42 | USD 27,100 | SEC filing ↗ |
| 2024-08-21 | ANDO GORAN | Purchase (P) | Common Stock | 5,000 | USD 7.95 | USD 39,750 | SEC filing ↗ |
| 2024-08-20 | DICICCO WENDY F | Purchase (P) | Common Stock | 2,567 | USD 7.79 | USD 19,997 | SEC filing ↗ |
| 2024-08-19 | Zaderej Karen L. | Purchase (P) | Common Stock | 12,500 | USD 7.98 | USD 99,750 | SEC filing ↗ |
| 2024-08-16 | Lurker Nancy | Purchase (P) | Common Stock | 3,173 | USD 7.88 | USD 25,003 | SEC filing ↗ |
| 2024-05-06 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP | Purchase (P) | Common Stock | 850,000 | USD 11.86 | USD 10,081,721 | SEC filing ↗ |
| 2024-04-18 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP | Purchase (P) | Common Stock | 581,765 | USD 18.03 | USD 10,489,446 | SEC filing ↗ |
| 2024-01-11 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP | Purchase (P) | Common Stock | 750,000 | USD 19.75 | USD 14,812,500 | SEC filing ↗ |
| 2024-01-09 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP | Purchase (P) | Common Stock | 105,000 | USD 21.32 | USD 2,238,600 | SEC filing ↗ |
| 2023-12-08 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP | Purchase (P) | Common Stock | 588,235 | USD 17.00 | USD 9,999,995 | SEC filing ↗ |
Form 4 evidence
44 transaction lines in the latest 365-day window; 310 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Elston George | J (J) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-20 | Elston George | Gift (G) | Common Stock | 64,953 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-18 | Zaderej Karen L. | Purchase (P) | Common Stock | 10,600 | USD 4.93 | USD 52,258 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Elston George | J (J) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-20 | Elston George | Gift (G) | Common Stock | 64,953 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-18 | Zaderej Karen L. | Purchase (P) | Common Stock | 10,600 | USD 4.93 | USD 52,258 | SEC filing ↗ |
| 2026-07-10 | Duker Jay S. | Option exercise / conversion (M) | Common Stock | 16,667 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-10 | Duker Jay S. | Tax withholding (F) | Common Stock | 8,059 | USD 14.72 | USD 118,628 | SEC filing ↗ |
| 2026-06-30 | Ribeiro Ramiro | Sale (S) | Common Stock | 4,875 | USD 15.01 | USD 73,174 | SEC filing ↗ |
| 2026-06-30 | Ribeiro Ramiro | Option exercise / conversion (M) | Common Stock | 4,875 | USD 8.26 | USD 40,268 | SEC filing ↗ |
| 2026-05-25 | Elston George | Option exercise / conversion (M) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-25 | Elston George | Tax withholding (F) | Common Stock | 3,627 | USD 12.93 | USD 46,897 | SEC filing ↗ |
| 2026-04-17 | Ribeiro Ramiro | Sale (S) | Common Stock | 2,437 | USD 15.00 | USD 36,555 | SEC filing ↗ |
| 2026-04-17 | Ribeiro Ramiro | Option exercise / conversion (M) | Common Stock | 2,437 | USD 8.26 | USD 20,130 | SEC filing ↗ |
| 2026-03-23 | Duker Jay S. | J (J) | Common Stock | 76,766 | USD 13.11 | USD 1,006,402 | SEC filing ↗ |
| 2026-03-16 | Duker Jay S. | Purchase (P) | Common Stock | 1,500 | USD 13.15 | USD 19,725 | SEC filing ↗ |
| 2026-03-04 | Ribeiro Ramiro | Sale (S) | Common Stock | 2,438 | USD 17.87 | USD 43,567 | SEC filing ↗ |
| 2026-03-04 | Ribeiro Ramiro | Option exercise / conversion (M) | Common Stock | 2,438 | USD 8.26 | USD 20,138 | SEC filing ↗ |
| 2026-03-02 | Elston George | Gift (G) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-17 | Ribeiro Ramiro | Sale (S) | Common Stock | 2,437 | USD 15.00 | USD 36,555 | SEC filing ↗ |
| 2026-02-17 | Ribeiro Ramiro | Option exercise / conversion (M) | Common Stock | 2,437 | USD 8.26 | USD 20,130 | SEC filing ↗ |
| 2026-01-06 | Lurker Nancy | Option exercise / conversion (M) | Common Stock | 75,133 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Elston George | Option exercise / conversion (M) | Common Stock | 15,285 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Elston George | Tax withholding (F) | Common Stock | 4,487 | USD 16.86 | USD 75,651 | SEC filing ↗ |
| 2026-01-06 | Duker Jay S. | Option exercise / conversion (M) | Common Stock | 20,793 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Duker Jay S. | Tax withholding (F) | Common Stock | 10,054 | USD 16.86 | USD 169,510 | SEC filing ↗ |
| 2026-01-05 | Ribeiro Ramiro | Sale (S) | Common Stock | 42,544 | USD 17.10 | USD 727,502 | SEC filing ↗ |
| 2026-01-05 | Ribeiro Ramiro | Option exercise / conversion (M) | Common Stock | 29,250 | USD 8.26 | USD 241,605 | SEC filing ↗ |
| 2026-01-05 | Lurker Nancy | Option exercise / conversion (M) | Common Stock | 12,666 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-05 | Elston George | Option exercise / conversion (M) | Common Stock | 15,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-05 | Elston George | Tax withholding (F) | Common Stock | 4,403 | USD 17.43 | USD 76,744 | SEC filing ↗ |
| 2026-01-05 | Duker Jay S. | Option exercise / conversion (M) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-05 | Duker Jay S. | Tax withholding (F) | Common Stock | 14,505 | USD 17.43 | USD 252,822 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | EYPT |
| CIK | 0001314102 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 310 transaction lines from 2020-02-21 to 2026-08-20 39 P purchase lines · 67 S sale lines · 204 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.